Detection of semenogelin 1 amyloidosis through immunohistochemical staining with novel antiserum developed based on mass spectrometric peptide mapping analysis
Amyloid
.
2022 Dec;29(4):278-280.
doi: 10.1080/13506129.2022.2101920.
Epub 2022 Jul 20.
Authors
Masayoshi Tasaki
1
2
,
Yohei Misumi
1
,
Toshiya Nomura
1
,
Tomomi Kamba
3
,
Mitsuharu Ueda
1
Affiliations
1
Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
2
Department of Biomedical Laboratory Sciences, Graduate School of Health Sciences, Kumamoto University, Kumamoto, Japan.
3
Department of Urology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
PMID:
35856672
DOI:
10.1080/13506129.2022.2101920
No abstract available
Publication types
Letter
MeSH terms
Amyloidosis* / diagnosis
Humans
Mass Spectrometry
Peptide Mapping
Staining and Labeling